Prosperity Consulting Group »

Black Diamond Therapeutics shares owned by Prosperity Consulting Group

Quarter-by-quarter ownership of Black Diamond Therapeutics (BDTX) shares owned by Prosperity Consulting Group from 13F filings

Historical chart of Prosperity Consulting Group investment in Black Diamond Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Black Diamond Therapeutics held by Prosperity Consulting Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Black Diamond Therapeutics by Prosperity Consulting Group

Quarter filed Position value Share count Share price at filing
2026-03-31 $24k 11k 2.13

More positions owned by Prosperity Consulting Group

Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Msci Eafe Etf (EFA)
J P Morgan Exchange Traded F Equity Premium (JEPI)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Rus Tp200 Gr Etf (IWY)
Apple (AAPL)
Vanguard World Mega Cap Val Etf (MGV)
Invesco Exch Traded Fd Tr Ii Nasdaq 100 Etf (QQQM)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Ishares Tr Ultra Short Dur (ICSH)
Ishares Tr Eafe Value Etf (EFV)
Ishares Tr Core Us Aggbd Et (AGG)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Select Sector Spdr Tr State Street Tec (XLK)
Vanguard Index Fds Mid Cap Etf (VO)

View all positions for Prosperity Consulting Group

Top funds holding Black Diamond Therapeutics

T. Rowe Price Investment Management
NEA Management Company
Acadian Asset Management
Vanguard Group
Dimensional Fund Advisors
Marshall Wace
BlackRock
Connor, Clark & Lunn Investment Management
Siren
Arrowstreet Capital, Limited Partnership
Renaissance Technologies
Mackenzie Financial
Goldman Sachs Group
Citadel Advisors
UBS Group

View all funds holding Black Diamond Therapeutics